黑棘皮病详细的分子发病机制目前仍有待发现,由于各种内分泌或肿瘤产生的生长因子对存在于表皮细胞的受体有影响,故而假设它们可能参与皮损的特征性改变。[2]Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994 Jul;31(1):1-19.http://www.ncbi.nlm.nih.gov/pubmed/8021347?tool=bestpractice.com[22]Torley D, Bellus GA, Munro CS. Genes, growth factors and acanthosis nigricans. Br J Dermatol. 2002 Dec;147(6):1096-101.http://www.ncbi.nlm.nih.gov/pubmed/12452857?tool=bestpractice.com[20]Houpt KR, Cruz PD. Acanthosis nigricans. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds, Fitzpatrick's dermatology in general medicine, 6th ed. New York, NY; McGraw Hill: 2003: 1796-1801.[23]Koyama S, Ikeda K, Sato M, et al. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol. 1997 Feb;32(1):71-7.http://www.ncbi.nlm.nih.gov/pubmed/9058298?tool=bestpractice.com[24]Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5(3):199-203.http://www.ncbi.nlm.nih.gov/pubmed/15186199?tool=bestpractice.com特别是表皮生长因子和转化生长因子 α,这两者可能与 AN 相关的肿瘤产生。[2]Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994 Jul;31(1):1-19.http://www.ncbi.nlm.nih.gov/pubmed/8021347?tool=bestpractice.com[23]Koyama S, Ikeda K, Sato M, et al. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol. 1997 Feb;32(1):71-7.http://www.ncbi.nlm.nih.gov/pubmed/9058298?tool=bestpractice.com在肥胖和糖尿病相关的黑棘皮病当中,各种内分泌产物的增长水平,包括胰岛素样生长因子-1(IGF-1)以及胰岛素本身,由于它们的受体存在于表皮角质细胞当中,可能在其中也有发挥作用。[2]Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994 Jul;31(1):1-19.http://www.ncbi.nlm.nih.gov/pubmed/8021347?tool=bestpractice.com[20]Houpt KR, Cruz PD. Acanthosis nigricans. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds, Fitzpatrick's dermatology in general medicine, 6th ed. New York, NY; McGraw Hill: 2003: 1796-1801.[23]Koyama S, Ikeda K, Sato M, et al. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol. 1997 Feb;32(1):71-7.http://www.ncbi.nlm.nih.gov/pubmed/9058298?tool=bestpractice.com[24]Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5(3):199-203.http://www.ncbi.nlm.nih.gov/pubmed/15186199?tool=bestpractice.com